Influence of diltiazem on the behavior of zolpidem-treated mice in the elevated-plus maze test

Journal of Neural Transmission

Volumn 114, Issue 2, 2007, Pages 155-160

  Cui, X Y ^a   Zhao, X ^a   Chu, Q P ^a   Chen, B Q ^a   Zhang, Y H ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Diltiazem; Elevated plus maze; mCPP; Serotonergic system; Zolpidem

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; 5 HYDROXYTRYPTOPHAN; CALCIUM CHANNEL; DILTIAZEM; ZOLPIDEM;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY DISORDER; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; MAZE TEST; MOUSE; NONHUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL; TRANQUILIZING ACTIVITY;

5-HYDROXYTRYPTOPHAN; ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; BENZODIAZEPINES; CALCIUM CHANNEL BLOCKERS; DILTIAZEM; GABA AGONISTS; MAZE LEARNING; MICE; PIPERAZINES; PYRIDINES; SEROTONIN AGONISTS;

EID: 33846440963     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-006-0535-1     Document Type: Article

References (39)

1. J Auta E Romeo A Kozikowski D Ma E Costa A Guidotti 1993 Participation of mitochondrial diazepam binding inhibitor receptors in the anticonflict, antineophobic and anticonvulsant action of 2-aryl-3-indoleacetamide and imidazopyridine derivatives J Pharmacol Exp Ther 265 649 656
2. 1B characterizing agents in the mouse elevated plus-maze Life Sci 47 195 203
3. G Biala B Weglinska 2005 Blockade of the expression of mecamylamine-precipitated nicotine withdrawal by calcium channel antagonists Pharmacol Res 51 483 488
4. SJ Czuczwar A Chodkowska Z Kleinrok U Malek E Jagiello-Wojtowicz 1990 Effects of calcium channel inhibitors upon the efficacy of common antiepileptic drugs Eur J Pharmacol 176 75 83
5. MF Davies ES Onaivi SW Chen PA Maguire NF Tsai GH Loew 1994 Evidence for central benzodiazepine receptor heterogeneity from behavior tests Pharmacol Biochem Behav 49 47 56
6. GR Dawson MD Tricklebank 1995 Use of the elevated plus maze in the search for novel anxiolytic agents Trends Pharmacol Sci 16 33 36
7. H Depoortere B Zivkovic KG Lloyd DJ Sanger G Perrault SZ Langer G Bartholini 1986 Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects J Pharmacol Exp Ther 237 649 658
8. SJ Dolin HJ Little 1986 Augmentation by calcium channel antagonists of general anaesthetic potency in mice Br J Pharmacol 88 909 914
9. SJ Dolin TL Patch M Rabbani PV Taberner HJ Little 1991 Differential interactions between benzodiazepines and the dihydropyridines, nitrendipine and Bay K 8644 Neuropharmacology 30 217 224
10. MB Gatch 2003 Discriminative stimulus effects of m-chlorophenylpiperazine as a model of the role of serotonin receptors in anxiety Life Sci 73 1347 1367
11. EL Gibson AM Barnfield G Curzon 1994 Evidence that mCPP-induced anxiety in the plus-maze is mediated by postsynaptic 5-HT2C receptors but not by sympathomimetic effects Neuropharmacology 33 457 465
12. G Griebel DJ Sanger G Perrault 1996a The use of the rat elevated plus-maze to discriminate between non-selective and BZ-1 (omega1) selective, benzodiazepine receptor ligands Psychopharmacology 124 245 254
13. G Griebel DJ Sanger G Perrault 1996b Further evidence for differences between non-selective and BZ-1 (omega1) selective, benzodiazepine receptor ligands in murine models of "state" and "trait" anxiety Neuropharmacology 35 1081 1091
14. G Griebel DJ Sanger G Perrault 1996c The mouse defense test battery: evaluation of the effects of non-selective and BZ-1 (omega1) selective, benzodiazepine receptor ligands Behav Pharmacol 7 560 572
15. G Griebel G Perrault DJ Sanger 1998 Limited anxiolytic-like effects of non-benzodiazepine hypnotics in rodents J Psychopharmacol 12 356 365
16. G Griebel G Perrault V Letang P Granger P Avenet H Schoemaker DJ Sanger 1999 New evidence that the pharmacological effects of benzodiazepine receptor ligands can be associated with activities at different BZ (omega) receptor subtypes Psychopharmacology 146 205 213
17. A receptor function by G protein-coupled 5-HT2C receptors Neuropharmacology 35 1355 1363
18. E Jankowska O Pucilowski W Kostowski 1991 Chronic oral treatment with diltiazem or verapamil decreases isolation-induced activity impairment in elevated plus maze Behav Brain Res 43 155 158
19. DJ Knapp DH Overstreet SS Moy GR Breese 2004 SB242084, flumazenil, and CRA1000 block ethanol withdrawal-induced anxiety in rats Alcohol 32 101 111
20. GA Kennett P Whitton K Shah G Curzon 1989 Anxiogenic-like effects of mCPP and TFMPP in animal models are opposed by 5-HT1C receptor antagonists Eur J Pharmacol 164 445 454
21. GA Kennett MD Wood F Bright B Trail G Riley V Holland KY Avenell T Stean N Upton S Bromidge IT Forbes AM Brown DN Middlemiss TP Blackburn 1997 SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist Neuropharmacology 36 609 620
22. E Lobarinas JL Falk 2000 Comparison of benzodiazepines and the non-benzodiazepine agents zolpidem and zaleplon with respect to anxiolytic action as measured by increases in hypertonic NaCl-solution drinking in rats Psychopharmacology 149 176 180
23. JR Martin TM Ballard GA Higgins 2002 Influence of the 5-HT2C receptor antagonist, SB-242084, in tests of anxiety Pharmacol Biochem Behav 71 615 625
24. RM McKernan TW Rosahl DS Reynolds C Sur KA Wafford JR Atack S Farrar J Myers G Cook P Ferris L Garrett L Bristow G Marshall A Macaulay N Brown O Howell KW Moore RW Carling LJ Street JL Castro CI Ragan GR Dawson PJ Whiting 2000 Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype Nat Neurosci 3 587 592
25. SS Moy DJ Knapp HE Criswell GR Breese 1997 Flumazenil blockade of anxiety following ethanol withdrawal in rats Psychopharmacology 131 354 360
26. A receptor complex ligands in two models of anxiety J Neural Transm 104 733 746
27. S Pellow P Chopin SE File M Briley 1985 Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat J Neurosci Methods 14 149 167
28. G Perrault E Morel DJ Sanger B Zivkovic 1990 Differences in pharmacological profiles of a new generation of benzodiazepine and non-benzodiazepine hypnotics Eur J Pharmacol 187 487 494
29. O Pucilowski 1992 Psychopharmacological properties of calcium channel inhibitors Psychopharmacology (Berl) 109 12 29
30. O Pucilowski W Kostowski 1991 Increased anxiety during ethanol and diazepam withdrawal in rats: effects of diltiazem and nicardipine Alcohol Clin Exp Res 15 331 334
31. DG Rainnie 1999 Serotonergic modulation of neurotransmission in the rat basolateral amygdala J Neurophysiol 82 69 85
32. U Rudolph F Crestani D Benke I Brunig JA Benson JM Fritschy JR Martin H Bluethmann H Mohler 1999 Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes Nature 401 796 800
33. DJ Sanger B Zivkovic 1986 The discriminative stimulus properties of zolpidem, a novel imidazopyridine hypnotic Psychopharmacology 89 317 322
34. MM Savic DI Obradovic ND Ugresic JM Cook W Yin DR Bokonjic 2004 Bidirectional effects of benzodiazepine binding site ligands in the elevated plus-maze: differential antagonism by flumazenil and beta-CCt Pharmacol Biochem Behav 79 279 290
35. J Serrats G Mengod R Cortes 2005 Expression of serotonin 5-HT2C receptors in GABAergic cells of the anterior raphe nuclei J Chem Neuroanat 29 83 91
36. S Sonkusare K Srinivasan C Kaul P Ramarao 2005 Effect of donepezil and lercanidipine on memory impairment induced by intracerebroventricular streptozotocin in rats Life Sci 77 1 14
37. P Soubrie 1989 Neuropsychological profiles of calcium antagonists Fundam Clin Pharmacol 3 Suppl 71s 78s
38. H Takahashi M Yoshimoto H Higuchi T Shimizu Y Hishikawa 1999 Different effects of L-type and T-type calcium channel blockers on the hypnotic potency of triazolam and zolpidem in rats Eur Neuropsychopharmacol 9 317 321
39. X Zhao XY Cui BQ Chen QP Chu HY Yao BS Ku YH Zhang 2004 Tetrandrine, a bisbenzylisoquinoline alkaloid from Chinese herb Radix, augmented the hypnotic effect of pentobarbital through serotonergic system Eur J Pharmacol 506 101 105